TITLE

Young at Heart

AUTHOR(S)
CURRY, ANDREW
PUB. DATE
October 2014
SOURCE
Diabetes Forecast;Oct2014, Vol. 67 Issue 10, p72
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses a study exploring how metformin therapy helps teenagers in avoiding heart diseases later in their life. The topics discussed include early onset of thickening of blood vessels in teenagers, the views of researcher Kristen Nadeau, on the issue, and the role of insulin resistance in development of heart diseases in persons with type 2 diabetes.
ACCESSION #
98489011

 

Related Articles

  • Structural and Functional Cardiac Abnormalities in Adolescent Girls with Poorly Controlled Type 2 Diabetes. Whalley, Gillian A.; Gusso, Silmara; Hofman, Paul; Cutfield, Wayne; Poppe, Katrina K.; Doughty, Robert N.; Baldi, J. Chris // Diabetes Care;May2009, Vol. 32 Issue 5, p883 

    OBJECTIVE -- Type 2 diabetes is associated with left ventricular hypertrophy (LVH) and diastolic dysfunction, which may eventually lead to clinical heart failure. We sought to determine the cardiovascular effects of adolescent-onset type 2 diabetes. RESEARCH DESIGN AND METHODS -- We recruited...

  • Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms. Laakso, Markku // Diabetes Care;Feb2010, Vol. 33 Issue 2, p442 

    The article discusses the risk of cardiovascular disease (CVD) in patients with type 2 diabetes. The author claims that a study, which he and his colleagues conducted, revealed that the risk level of myocardial infarction (MI) in patients with type 2 diabetes is as high as that of nondiabetic...

  • Insulin Resistance, Inflammation and Atherosclerosis. Ahmad, Jamal; Khan, Abdur Rahman // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Sep2008, Vol. 7 Issue 3, p172 

    Type 2 diabetes and obesity are major risk factors for the development of coronary artery disease (CAD), and premature atherosclerosis. Both conditions are associated with insulin resistance, oxidative stress, and inflammation. Several factors that increase the risk of cardiovascular disease...

  • Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study. Dai-Yin Lu; Chin-Chou Huang; Po-Hsun Huang; Chia-Min Chung; Shing-Jong Lin; Jaw-Wen Chen; Wan-Leong Chan; Hsin-Bang Leu // BMC Cardiovascular Disorders;2014, Vol. 14 Issue 1, p198 

    Background: Metformin, an insulin-sensitizer, may correct several physiologic abnormalities owing to insulin resistance in patients with type 2 diabetes mellitus (DM). The effects of metformin on venous thrombosis in patient with type 2 DM have not been reported. Our study strived to explore the...

  • Tailor treatment of type 2 diabetes mellitus in children and adolescents to the individual requirements of each patient.  // Drugs & Therapy Perspectives;Sep2007, Vol. 23 Issue 9, p9 

    The article reports on treating children and teenagers with type 2 diabetes mellitus. It was reported that there the number of children and adolescents with type 2 diabetes is increasing. Insulin resistance is one of the factors that causes type 2 diabetes. Normalization of blood glucose and...

  • The link between diabetes and polycystic ovary syndrome. Prasad Pothina, Narayana; Jennings, Paul // Practice Nursing;Mar2013, Vol. 24 Issue 3, p120 

    The article discusses the link between diabetes and polycystic ovary syndrome (PCOS). It mentions that feature of PCOS is insulin resistance and is caused due to its complex and multifactorial genetic and environmental factors. It is also mentioned that PCOS is the most common endocrine...

  • Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes.  // Diabetes Care;Jun2013, Vol. 36 Issue 6, p1765 

    OBJECTIVE--Data related to the safety and tolerability of treatments for pediatric type 2 diabetes are limited. The TODAY clinical trial assessed severe adverse events (SAEs) and targeted nonsevere adverse events (AEs) before and after treatment failure, which was the primary outcome (PO)....

  • Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment1,2. Chevalier, Stéphanie; Farsijani, Samaneh // Applied Physiology, Nutrition & Metabolism;Jun2014, Vol. 39 Issue 6, p643 

    Cancer cachexia is a metabolic syndrome featuring many alterations typical of type 2 diabetes (T2D). While muscle wasting is a hallmark of cachexia, epidemiological evidence also supports an accelerated age-related muscle loss in T2D. Insulin resistance manifests in both conditions and impairs...

  • Profiling of Circulating Norton Reveals Common Norton Linked to Type 2 Diabetes That Change With Insulin Sensitization. Ortega, Francisco J.; Mercader, Josep M.; Moreno-Navarrete, José María; Rovira, Oscar; Guerra, Ester; Esteve, Eduardo; Xifra, Gemma; Martínez, Cristina; Ricart, Wifredo; Rieusset, Jennifer; Rome, Sophie; Karczewska-Kupczewska, Monika; Straczkowski, Marek; Fernández-Real, Jose Manuel // Diabetes Care;May2014, Vol. 37 Issue 5, p1375 

    OBJECTIVE This study sought to identify the pro le of circulating microRNAs (miRNAs) in type 2 diabetes (T2D) and its response to changes in insulin sensitivity. RESEARCH DESIGN AND METHODS The circulating miRNA pro le was assessed in a pilot study of 12 men: 6 with normal glucose tolerance...

  • Soluble L-Selectin Level Is a Marker for Coronary Artery Disease in Type 2 Diabetic Patients. Albertini, Jean-Paul; Valensi, Paul; Lormeau, Boris; Vaysse, Jenny; Attali, Jean-Raymond; Gattegno, Liliane // Diabetes Care;Dec99, Vol. 22 Issue 12, p2044 

    Presents information on a study which investigated whether the decline in soluble L-selectin level constitutes a marker for mycardial ischemia in type 2 diabetic patients. Account of related studies; Research design and methods; Results and discussion.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics